Design of tailor-made micro-carrier protein having molecular-selective recognition.

具有分子选择性识别的定制微载体蛋白的设计。

基本信息

  • 批准号:
    17300165
  • 负责人:
  • 金额:
    $ 9.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

Small-angle X-ray scattering (SAXS) of lipocalin-type prostaglandin D synthase (L-PGDS) and two other lipocalins, β-lactoglobulin (βLG) and retinal-binding protein (RBP) were measured to clarify their conformational changes induced by binding of small lipophilic ligands, such as all-trans-retinoic acid (RA), bilirubin (BR) and biliverdin (BV). The radius of gyration (R_g) was estimated to be 19.4Å for L-PGDS, and 18.8Å for L-PGDS/RA, 17.3Å for L-PGDS/BR and 17.8Å for L-PGDSn3V complexes, indicating that L-PGDS became compact after binding of these ligands. Alternatively, the R_g of βLG and RBP (20.3 and 26.2Å, respectively) was almost unchanged before and after binding of RA. Molecular modeling of L-PGDS based on the SAXS data indicated that the ligand binding changed the peripheral region of the molecule and suggested that such structural flexibility of the L-PGDS molecule is responsible for the broader ligand selectivity of L-PGDS than other lipocalins.The three-dimensional structure of recombinant mouse L-PGDS was determined by NMR. The structure of L-PGDS exhibited the typical lipocalin-fold, consisting of an 8-stranded, antiparallel β-barrel and a α-helix associated with the outer surface of the barrel. The interior of the barrel formed a hydrophobic cavity opening to the upper end of the barrel, the size of which was larger than those of other lipocalins and the cavity contained two pockets. Molecular docking studies based on the result of NMR experiments with RA and PGH_2 analog revealed that PGH_2 fully occupied the hydrophilic pocket 1, where Cys65 was located, and RA did the hydrophobic pocket 2, where amino acid residues important for retinoid-binding in other lipocalins were well conserved. These results indicated that the two binding sites in the large cavity of L-PGDS was responsible for the broad ligand specificity of L-PGDS and the non-competitive inhibition of L-PGDS activity by RA.
用小角X射线散射(SAXS)方法研究了脂笼蛋白型前列腺素D合成酶(L-PGDS)、β-乳球蛋白(β-lactoglobulin,βLG)和视黄结合蛋白(retinal-binding protein,RBP)与全反式维甲酸(all-trans-retinoic acid,RA)、胆红素(bilirubin,BR)和胆绿素(biliverdin,BV)等亲脂配体结合后的构象变化。L-PGDS/RA、L-PGDS/BR和L-PGDSn 3V复合物的回转半径分别为19.4、18.8、17.3和17.8 μ m,表明L-PGDS与这些配体结合后变得紧密。β-LG和RBP的R_g在与RA结合前后几乎没有变化(分别为20.3和26.2 μ g)。基于SAXS数据的L-PGDS的分子模拟表明,配体结合改变了分子的外围区域,并表明L-PGDS分子的这种结构灵活性是L-PGDS比其他脂质运载蛋白更广泛的配体选择性的原因。L-PGDS的结构表现出典型的脂质运载蛋白折叠,由一个8链的反平行β-桶和一个与桶外表面相关的α-螺旋组成。筒的内部形成了一个疏水性空腔,开口朝向筒的上端,其尺寸大于其他脂质运载蛋白的尺寸,并且空腔包含两个口袋。基于核磁共振实验结果的分子对接研究表明,PGH_2完全占据了亲水口袋1中Cys 65的位置,而RA占据了疏水口袋2中其他脂质运载蛋白中与类维生素A结合的重要氨基酸残基。这些结果表明,L-PGDS大空腔中的两个结合位点是L-PGDS广泛的配体特异性和RA对L-PGDS活性的非竞争性抑制的原因。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Thermal stability of lipocalin-type prostaglandin D synthase induced by hydrophobic small ligand.
疏水性小配体诱导的脂质运载蛋白型前列腺素 D 合酶的热稳定性。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Saitoh;R.;Suzuki;T.;Yoneyama;T.;Mutoh;S.;Hasegawa;K.;Munehiro;M.;Niwa;K.;Watanabe;T.;Ohyama;T;Toshihiro Watanabe;Daisuke Irikura;Yoshitaka Nagai;Daisuke Irikura;Yoshitaka Nagai;Ikuko Mohri;Ko Fujimori;Osamu Ishibashi;飯田津喜美;Ikuko Mohri;Tsukimi Iida;Ikuko Mohri;飯田津喜美;Ko Fujimori;Tsukimi Iida;Bruno Kilunga Kubata;西口茉実;Bruno Kilunga Kubata;Tsukimi Iida;Nishiguchi Mami
  • 通讯作者:
    Nishiguchi Mami
疎水性低分子結合によるリポカリン型プロスタグランジンD合成酵素の熱安定性についての研究
疏水性小分子结合研究脂质运载蛋白型前列腺素D合酶的热稳定性
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Saitoh;R.;Suzuki;T.;Yoneyama;T.;Mutoh;S.;Hasegawa;K.;Munehiro;M.;Niwa;K.;Watanabe;T.;Ohyama;T;Toshihiro Watanabe;Daisuke Irikura;Yoshitaka Nagai;Daisuke Irikura;Yoshitaka Nagai;Ikuko Mohri;Ko Fujimori;Osamu Ishibashi;飯田津喜美;Ikuko Mohri;Tsukimi Iida;Ikuko Mohri;飯田津喜美;Ko Fujimori;Tsukimi Iida;Bruno Kilunga Kubata;西口茉実
  • 通讯作者:
    西口茉実
Characterization of a major secretory protein in the cane toad (Bufo marinus) choroid plexus as an amphibian lipocalin-type prostaglandin D synthase.
甘蔗蟾蜍 (Bufo marinus) 脉络丛中主要分泌蛋白的表征,为两栖类脂质运载蛋白型前列腺素 D 合酶。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Saitoh;R.;Suzuki;T.;Yoneyama;T.;Mutoh;S.;Hasegawa;K.;Munehiro;M.;Niwa;K.;Watanabe;T.;Ohyama;T;Toshihiro Watanabe;Daisuke Irikura
  • 通讯作者:
    Daisuke Irikura
Structural and mutational analysis of Trypanosoma brucei prostaglandin H_2 reductase provides insight into the catalytic mechanism of aldo-ketoreductases.
布氏锥虫前列腺素 H_2 还原酶的结构和突变分析有助于深入了解醛酮还原酶的催化机制。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Saitoh;R.;Suzuki;T.;Yoneyama;T.;Mutoh;S.;Hasegawa;K.;Munehiro;M.;Niwa;K.;Watanabe;T.;Ohyama;T;Toshihiro Watanabe;Daisuke Irikura;Yoshitaka Nagai;Daisuke Irikura;Yoshitaka Nagai;Ikuko Mohri;Ko Fujimori;Osamu Ishibashi;飯田津喜美;Ikuko Mohri;Tsukimi Iida;Ikuko Mohri;飯田津喜美;Ko Fujimori;Tsukimi Iida;Bruno Kilunga Kubata;西口茉実;Bruno Kilunga Kubata
  • 通讯作者:
    Bruno Kilunga Kubata
Thermal unfolding mechanism of lipocalin-type prostaglandin D synthase induced by hydrophobic small ligand.
疏水性小配体诱导脂质运载蛋白型前列腺素 D 合酶的热解折叠机制。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Saitoh;R.;Suzuki;T.;Yoneyama;T.;Mutoh;S.;Hasegawa;K.;Munehiro;M.;Niwa;K.;Watanabe;T.;Ohyama;T;Toshihiro Watanabe;Daisuke Irikura;Yoshitaka Nagai;Daisuke Irikura;Yoshitaka Nagai;Ikuko Mohri;Ko Fujimori;Osamu Ishibashi;飯田津喜美;Ikuko Mohri;Tsukimi Iida
  • 通讯作者:
    Tsukimi Iida
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

INUI Takashi其他文献

INUI Takashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('INUI Takashi', 18)}}的其他基金

A Study on Automatic Indexing Based on Textual Mentions to Geographical Location in Story Archiving
故事归档中基于地理位置文本提及的自动索引研究
  • 批准号:
    18K11982
  • 财政年份:
    2018
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Study of Detecting "bad mouth" Comments in Social Media based on Actual Usage of Language Expressions
基于语言表达实际使用的社交媒体中“坏话”评论检测研究
  • 批准号:
    15K20884
  • 财政年份:
    2015
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of intelligent-type drug delivery system by transporter protein.
转运蛋白智能型药物递送系统的开发。
  • 批准号:
    21200076
  • 财政年份:
    2009
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Innovative Areas (Research a proposed research project)

相似海外基金

SpyTCR-RBNP - Engineering a highly targeted and biocompatible drug delivery system for solid cancer treatment
SpyTCR-RBNP - 设计用于实体癌症治疗的高度针对性和生物相容性的药物输送系统
  • 批准号:
    10095606
  • 财政年份:
    2024
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Collaborative R&D
骨軟部肉腫に対するカーボン製drug delivery systemの開発
骨软组织肉瘤碳药物递送系统的开发
  • 批准号:
    24K12414
  • 财政年份:
    2024
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Drug delivery system of osteoclast differentiation inhibitor with carbonate apatite
碳酸磷灰石破骨细胞分化抑制剂的给药系统
  • 批准号:
    23K16044
  • 财政年份:
    2023
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Smart Nano-carrier for drug delivery system encapsulating peptide drug with high-efficiency
高效包裹肽类药物的药物递送系统智能纳米载体
  • 批准号:
    23K13803
  • 财政年份:
    2023
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of Non-contact Nucleic Acid Drug Delivery System to Whole Body Skin - Challenge to SF Culture Tank -
开发全身皮肤非接触式核酸给药系统 - 挑战SF培养罐 -
  • 批准号:
    23K18592
  • 财政年份:
    2023
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Pioneering research on development of "Drug Delivery System" for deworming gastrointestinal-infected Anisakis
开创性研究开发“药物输送系统”以驱除胃肠道感染的异尖线虫
  • 批准号:
    23K17446
  • 财政年份:
    2023
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Development of an innovative drug delivery system for cancer therapy using platelets as vectors
使用血小板作为载体开发用于癌症治疗的创新药物输送系统
  • 批准号:
    23H02769
  • 财政年份:
    2023
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of Drug Delivery System for RI Drugs Using Chromophore - Assisted Light Inactivation and Computational Science
利用发色团开发 RI 药物的给药系统 - 辅助光灭活和计算科学
  • 批准号:
    22KJ0538
  • 财政年份:
    2023
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Topical Drug Delivery System as an Anti-Inflammatory and Pro-Angiogenic Therapy for Diabetic Wound Healing
局部给药系统作为糖尿病伤口愈合的抗炎和促血管生成疗法
  • 批准号:
    10696266
  • 财政年份:
    2023
  • 资助金额:
    $ 9.54万
  • 项目类别:
Targeted drug delivery system to overcome blood-brain barrier and therapeutic resistance to current standard of care in Glioblastoma
靶向药物输送系统可克服血脑屏障和对胶质母细胞瘤现行护理标准的治疗耐药性
  • 批准号:
    10659749
  • 财政年份:
    2023
  • 资助金额:
    $ 9.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了